Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading on Wednesday. Stock investors acquired 1,885 put options on the company. This is an increase of approximately 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Price Performance

EVLO opened at $0.00 on Friday. The firm has a market capitalization of $5,694.90, a PE ratio of 0.00 and a beta of 1.58. The business’s 50-day moving average is $0.02 and its two-hundred day moving average is $0.04. Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $1.33.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.